The European Vaccine Initiative (EVI, Germany), is a not-for-profit organisation that supports the development of safe, effective and affordable vaccines for global health. Since its inception in 1998, EVI worked closely with partners and donors worldwide to move 40 vaccine formulations forward. It is a science-driven organisation, leading innovative solutions for vaccine R&D through cross-cutting activities, capacity strengthening and advocacy. EVI operates with support from the European Commission, the European & Developing Countries Clinical Trials Partnership (EDCTP), the Innovative Medicines Initiative (IMI), the Global Health Innovative Technology Fund (GHIT and others. EVI is hosted by Heidelberg University in Germany.

 

www.euvaccine.eu